Garcia Ana Rita, Vaz Ana Rita, Malhó Rui, Botelho Hugo M, Figueira Inês, Brito Maria Alexandra
Faculty of Pharmacy, imed - Research Institute for Medicines, Universidade de Lisboa, Av. Prof. Gama Pinto, Lisbon, 1649-003, Portugal.
Faculty of Pharmacy, Department of Pharmaceutical Sciences and Medicines, Unversidade de Lisboa, Av. Prof. Gama Pinto, Lisbon, 1649-003, Portugal.
Acta Neuropathol Commun. 2025 Aug 28;13(1):185. doi: 10.1186/s40478-025-01985-2.
Brain metastases (BM) critically reduce breast cancer (BC) patients' survival. Extravasation is pivotal for BM development, but the underlying events at the blood-brain barrier (BBB) remain elusive. We aimed to unravel the players and mechanisms governing BC cells (BCCs)-BBB interaction. For that, mixed cultures of human brain microvascular endothelial cells (HBMECs), mimicking the BBB, and brain-tropic triple-negative BCCs (MDA-MB-231 Br4), or non-brain-tropic (MDA-MB-231) or non-metastatic cells (MCF-7) were established. Temporal and spatial analysis of BCCs-BBB interactions (live-cell imaging automated microscopy), and assessments of endothelial-to-mesenchymal transition (EndMT) markers, transcription factors, cytoskeletal proteins, and morphology (immunocytochemistry) were performed. BBB integrity (permeability, transendothelial electrical resistance) and endothelial migration (wound-healing) were also assessed. Our results revealed that contrasting with non-metastatic and non-brain-tropic cells, BCCs quickly developed an invasive, migratory phenotype, characterized by invadopodium formation and reduced roundness. Spatial analysis showed different positioning of BCCs relative to the BBB endothelium over time, with 14% of BCCs transmigrated after 3 h, compromising BBB integrity through endothelial holes, reduced tightness, and increased permeability. Prior to transmigration, alterations in adhesion markers (E-selectin, ICAM-1, CD24, CD34, β3-integrin, Sialyl-Lewis X) were observed. EndMT was also evident by decreased endothelial (β-catenin and pan cytokeratin) and increased mesenchymal (vimentin, neuronal-cadherin, Slug, ZEB1) markers, elongation (RhoA, α-SMA), nuclear deformation, and migratory capacity. Caveolin-1 silencing in HBMEC decreased BCCs transmigration. This study reveals significant BBB phenotypic and structural changes, facilitating both paracellular and transcellular BCCs transmigration. These findings provide advanced understanding of BCCs trafficking across the BBB, aiding strategy development to prevent extravasation and BM.
脑转移(BM)严重降低乳腺癌(BC)患者的生存率。外渗对于脑转移的发展至关重要,但血脑屏障(BBB)处的潜在事件仍不清楚。我们旨在揭示调控乳腺癌细胞(BCCs)与血脑屏障相互作用的因素和机制。为此,建立了模拟血脑屏障的人脑微血管内皮细胞(HBMECs)与嗜脑三阴性乳腺癌细胞(MDA-MB-231 Br4)、非嗜脑(MDA-MB-231)或非转移性细胞(MCF-7)的混合培养体系。对BCCs与血脑屏障的相互作用进行了时空分析(活细胞成像自动显微镜),并评估了内皮-间充质转化(EndMT)标志物、转录因子、细胞骨架蛋白和形态(免疫细胞化学)。还评估了血脑屏障的完整性(通透性、跨内皮电阻)和内皮迁移(伤口愈合)。我们的结果显示,与非转移性和非嗜脑细胞相比,BCCs迅速形成侵袭性、迁移性表型,其特征为形成侵袭伪足和圆度降低。空间分析表明,随着时间的推移,BCCs相对于血脑屏障内皮的定位不同,3小时后14%的BCCs发生迁移,通过内皮孔破坏血脑屏障的完整性,降低紧密性并增加通透性。在迁移之前,观察到粘附标志物(E-选择素、细胞间粘附分子-1、CD24、CD34、β3-整合素、唾液酸化路易斯X)的改变。EndMT也很明显,表现为内皮标志物(β-连环蛋白和泛细胞角蛋白)减少,间充质标志物(波形蛋白、神经钙粘蛋白、Slug、锌指E盒结合蛋白1)增加,伸长(RhoA、α-平滑肌肌动蛋白)、核变形和迁移能力增强。HBMEC中窖蛋白-1沉默减少了BCCs的迁移。本研究揭示了血脑屏障显著的表型和结构变化,促进了BCCs的细胞旁和跨细胞迁移。这些发现为深入了解BCCs穿越血脑屏障的过程提供了帮助,有助于制定预防外渗和脑转移的策略。